Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study
- 19 February 2021
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 96 (5), 561-570
- https://doi.org/10.1002/ajh.26134
Abstract
Globally, postpartum hemorrhage (PPH) is the leading cause of maternal death. Women with immune thrombocytopenia (ITP) are at increased risk of developing PPH. Early identification of PPH helps to prevent adverse outcomes, but is underused because clinicians do not have a tool to predict PPH for women with ITP. We therefore conducted a nationwide multicenter retrospective study to develop and validate a prediction model of PPH in patients with ITP. We included 432 pregnant women (677 pregnancies) with primary ITP from 18 academic tertiary centers in China from January 2008 to August 2018. A total of 157 (23.2%) pregnancies experienced PPH. The derivation cohort included 450 pregnancies. For the validation cohort, we included 117 pregnancies in the temporal validation cohort and 110 pregnancies in the geographical validation cohort. We assessed 25 clinical parameters as candidate predictors and used multivariable logistic regression to develop our prediction model. The final model included seven variables and was named MONITOR (maternal complication, WHO bleeding score, antepartum platelet transfusion, placental abnormalities, platelet count, previous uterine surgery, and primiparity). We established an easy‐to‐use risk heatmap and risk score of PPH based on the seven risk factors. We externally validated this model using both a temporal validation cohort and a geographical validation cohort. The MONITOR model had an AUC of 0.868 (95% CI 0.828–0.909) in internal validation, 0.869 (95% CI 0.802–0.937) in the temporal validation, and 0.811 (95% CI 0.713–0.908) in the geographical validation. Calibration plots demonstrated good agreement between MONITOR‐predicted probability and actual observation in both internal validation and external validation. Therefore, we developed and validated a very accurate prediction model for PPH. We hope that the model will contribute to more precise clinical care, decreased adverse outcomes, and better health care resource allocation.Funding Information
- Beijing Municipal Science and Technology Commission (Z171100001017084)
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001)
- National Basic Research Program of China (2017YFA0105500, 2017YFA0105503)
- National Natural Science Foundation of China (81970113, 81730004, 81670116)
- Natural Science Foundation of Beijing Municipality (7171013, 7171013)
This publication has 47 references indexed in Scilit:
- How I treat thrombocytopenia in pregnancyBlood, 2013
- Risk factors for postpartum hemorrhage in a cohort of 6011 Italian womenThrombosis Research, 2012
- Postpartum hemorrhage in low risk populationjpme, 2011
- Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative GroupBMC Pregnancy and Childbirth, 2009
- The ITP syndrome: pathogenic and clinical diversityBlood, 2009
- Investigation of an increase in postpartum haemorrhage in CanadaBJOG: An International Journal of Obstetrics and Gynaecology, 2007
- Relaxing the Rule of Ten Events per Variable in Logistic and Cox RegressionAmerican Journal of Epidemiology, 2006
- Preventability of Pregnancy-Related DeathsObstetrics & Gynecology, 2005
- Outcome of pregnancy in a woman with an increased body mass indexBJOG: An International Journal of Obstetrics and Gynaecology, 2005
- Idiopathic thrombocytopenic purpura complicating pregnancyBlood Reviews, 2002